Karius

Karius is a life sciences company focused on transforming infectious disease diagnostics, using next-generation sequencing to analyze microbial cell-free DNA. The Karius platform and clinical-grade curated pathogen reference database deliver deep insight into the microbial landscape, providing clinicians with a comprehensive, quantitative test that can identify over 1,000 pathogens directly from blood within one day. The Karius technology, initially licensed from Stanford University, is based on sequencing and analyzing microbial cell-free DNA circulating in the bloodstream. Proprietary molecular biology, data analytics, and machine learning algorithms allow Karius to provide a comprehensive, non-invasive, and quantitative analysis of microbes across bacteria, DNA viruses, fungi, protozoa, and nematodes.